William B. Walkup & Associates’s Chemours CC Stock Holding History

William B. Walkup & Associates’s Portfolio CC Stock Details CC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$61.8K	Sell	4,554 -16	-0.4%	-$258	0.03%	99
2026 Q2	$93.8K	Sell	4,570 -46	-1%	-$1.05K	0.05%	98
2026 Q1	$62.5K	Buy	4,616 +3	+0.1%	+$52	0.04%	98
2025 Q4	$54.4K	Hold	4,613	–	–	0.03%	101
2025 Q3	$73.1K	Sell	4,613 -3	-0.1%	-$44	0.04%	94
2025 Q2	$52.9K	Hold	4,616	–	–	0.03%	98
2025 Q1	$62.5K	Hold	4,616	–	–	0.04%	97
2024 Q4	$78K	Hold	4,616	–	–	0.05%	97
2024 Q3	$93.8K	Sell	4,616 -123	-3%	-$2.51K	0.06%	94
2024 Q2	$107K	Buy	+4,739	New	+$124K	0.07%	91

Other funds holding CC

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Jefferies Financial Group New York $13.5B AUM 36.68% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $57.2B AUM 42.49% 1-Year Est. Return

Penn Capital Management Philadelphia, Pennsylvania $1.37B AUM 42.56% 1-Year Est. Return

UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $195B AUM 21.17% 1-Year Est. Return

AFA

Alta Fundamental Advisers New York $232M AUM 38.39% 1-Year Est. Return

William B. Walkup & Associates's CC Position: Q3 2026 in Review

William B. Walkup & Associates reduced its Chemours (CC) stake by 0.35% in Q3 2026, selling an estimated $258 and leaving 4,554 shares worth $61.8K. The position accounts for 0.03% of the portfolio, ranked #99.

William B. Walkup & Associates first reported a position in CC in Q2 2024 and has held it in 10 quarters since. The position peaked at $107K in Q2 2024. 262 funds tracked by Wall St. Rank hold CC as of Q3 2026.

William B. Walkup & Associates held 4,554 shares of Chemours worth $61.8K as of Q3 2026.
William B. Walkup & Associates sold 16 Chemours shares in Q3 2026, an estimated $258.
Chemours made up 0.03% of William B. Walkup & Associates's portfolio in Q3 2026, its #99 holding.
William B. Walkup & Associates first reported a position in Chemours in Q2 2024 and has held it in 10 quarters since.
William B. Walkup & Associates's Chemours position peaked at $107K in Q2 2024.
262 funds tracked by Wall St. Rank held Chemours as of Q3 2026.

Based on William B. Walkup & Associates's 13F filing for Q3 2026, filed 5 Nov 2026.